Related Experiment Video
Updated: Feb 8, 2026

08:44
Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
12.8K
Macrophage autophagy in atherosclerosis.
Maria Chiara Maiuri1, Gianluca Grassia, Andrew M Platt
1Department of Experimental Pharmacology, University of Naples Federico II, 80131 Naples, Italy.
Mediators of Inflammation
|February 13, 2013
Summary
Macrophage autophagy (AP) is vital in atherosclerosis. While protective early on, dysfunctional AP in later stages drives vascular inflammation and plaque damage, offering therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Cardiovascular Research
Background:
- Macrophages are key immune cells in atherosclerosis.
- Macrophage autophagy (AP) is a cellular process for degrading and recycling components.
- Dysfunctional AP contributes to vascular inflammation and plaque progression.
Purpose of the Study:
- To discuss the role of macrophages and AP in atherosclerosis.
- To review emerging evidence on AP's contribution to vascular pathology.
- To explore therapeutic potential of targeting AP.
Main Methods:
- Literature review and synthesis of current research on macrophage autophagy in atherosclerosis.
Main Results:
- Basal AP is atheroprotective in early atherosclerosis.
- AP dysfunction in advanced disease promotes inflammation, oxidative stress, and necrosis.
- Evidence links impaired AP to increased vascular pathology.
Conclusions:
- Macrophage AP plays a dual role in atherosclerosis, being protective early but detrimental when dysfunctional.
- Targeting macrophage AP presents a promising therapeutic strategy for atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
433
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
433
Atherosclerosis IV: Nursing Management
460
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
460
Atherosclerosis I: Introduction
1.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
548
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
548
Autophagy
5.9K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
What is the Immune System?
130.8K
Overview
130.8K

